Novartis India500672New rating assigned
CARE A; Stable assigned to Evonile Pharma's long-term bank facilities, CARE A2+ for short-term
CARE AAssigned · CARE Ratings Limited
- Long Term Rating
- CARE A; Stable
- Short Term Rating
- CARE A2+
- Rating Assignment Date
- October 07, 2026
- Agency
- CARE Ratings Limited
- Action
- Assigned
CARE A; Stable assigned to Evonile Pharma's long-term bank facilities, CARE A2+ for short-term.
Also from Novartis India
Board meeting on October 08, 2026 to consider fund-raise via rights issue of equity shares
5 Oct 2026
Name changed to Evonile Pharma Limited with effect from October 01, 2026; fresh Certificate of Incorporation issued
1 Oct 2026
Company name changed from Novartis India Limited to Evonile Pharma Limited with effect from October 01, 2026
1 Oct 2026
Source: BSE · 7 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.